Inotek Pharmaceuticals Corp. (ITEK)

Trade ITEK now with
9/12/2017 4:22:16 PM Inotek Pharmaceuticals Trading Halted ; Expected To Resume At 4:45 PM ET
9/12/2017 4:13:44 PM Inotek Pharmaceuticals Trading Halted Pending News
5/10/2017 7:15:15 AM Inotek Pharma Posts Q1 Net Loss Of $10.67 Mln Or $0.40/share
4/11/2017 7:04:18 AM Inotek Completes Patient Recruitment In Phase 2 Trial Of Fixed-dose Combination Of Trabodenoson And Latanoprost
3/16/2017 7:07:05 AM Inotek 2016 Loss Per Share $1.60 Vs Loss $3.72 Prior Year
9/29/2016 7:02:45 AM Inotek Names Timothy Barberich To Its Board
8/24/2016 7:02:27 AM Inotek Pharma Completes Recruitment Phase Of MATrX-1, The First Phase 3 Clinical Trial Of Trabodenoson For Glaucoma
8/23/2016 8:34:37 AM Kalytera Therapeutics Appoints Andrew Salzman As Chief Medical Officer